ulipristal acetate has been researched along with Endometrial Hyperplasia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cheung, CW; Fung, WY; Liang, B; Wang, CC; Wong, SW; Wu, L; Xu, H | 1 |
Barlow, DH; Bergeron, C; Ferenczy, A; Williams, AR | 1 |
1 trial(s) available for ulipristal acetate and Endometrial Hyperplasia
Article | Year |
---|---|
Endometrial morphology after treatment of uterine fibroids with the selective progesterone receptor modulator, ulipristal acetate.
Topics: Adolescent; Adult; Biopsy; Double-Blind Method; Endometrial Hyperplasia; Endometrium; Female; Humans; Leiomyoma; Middle Aged; Norpregnadienes; Receptors, Progesterone | 2012 |
1 other study(ies) available for ulipristal acetate and Endometrial Hyperplasia
Article | Year |
---|---|
Efficacy, safety and recurrence of new progestins and selective progesterone receptor modulator for the treatment of endometriosis: a comparison study in mice.
Topics: Animals; Apoptosis; Atrophy; Cell Proliferation; Dydrogesterone; Endometrial Hyperplasia; Endometriosis; Endometrium; Female; Mice; Mice, Inbred C57BL; Nandrolone; Norpregnadienes; Progestins; Receptors, Progesterone; Recurrence | 2018 |